Cargando…
New Selective Estrogen Receptor Modulators (SERMs) in Development
Selective estrogen receptor modulators (SERMs) or estrogen agonists/antagonists have shown promise in osteoporosis in that they have the potential to reduce the risk of fracture, and also reduce the risk of breast cancer. SERMs maybe classified according to their core structure, which is typically a...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Current Science Inc.
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902741/ https://www.ncbi.nlm.nih.gov/pubmed/20603714 http://dx.doi.org/10.1007/s11914-010-0025-0 |